Symbols / CLLS Stock $3.94 -1.02% Cellectis S.A.

Healthcare • Biotechnology • France • NGM
CLLS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 396.29M Enterprise Value 169.22M Income -67.59M Sales 79.59M Book/sh 1.05 Cash/sh 2.84
Dividend Yield Payout 0.00% Employees 224 IPO P/E Forward P/E -6.35
PEG P/S 4.98 P/B 3.76 P/C EV/EBITDA -7.78 EV/Sales 2.13
Quick Ratio 1.59 Current Ratio 1.62 Debt/Eq 114.22 LT Debt/Eq EPS (ttm) -0.67 EPS next Y -0.62
EPS Growth Revenue Growth -19.50% Earnings 2026-05-18 ROA -5.84% ROE -65.33% ROIC
Gross Margin 100.00% Oper. Margin -142.14% Profit Margin -84.92% Shs Outstand 72.59M Shs Float 46.68M Short Float 0.65%
Short Ratio 6.71 Short Interest 52W High 5.48 52W Low 1.33 Beta 2.71 Avg Volume 45.31K
Volume 4.85K Target Price $7.25 Recom Buy Prev Close $3.98 Price $3.94 Change -1.02%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-6.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest CLLS news.

Insider Transactions

No recent insider transactions.

Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category